Michael Schlichting

Darmstadt, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy.

A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy.

Journal: Journal of psychopharmacology (Oxford, England)

Published: June 10, 2025

Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy.

Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy.

Journal: Future oncology (London, England)

Published: May 19, 2025

SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.

SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.

Journal: The Lancet. Oncology

Published: March 30, 2025

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.

Journal: The Lancet. Oncology

Published: February 19, 2025

Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Analyses of Patient-reported Outcomes and Quality-adjusted Time Without Symptoms or Toxicity from the JAVELIN Bladder 100 Trial.

Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Analyses of Patient-reported Outcomes and Quality-adjusted Time Without Symptoms or Toxicity from the JAVELIN Bladder 100 Trial.

Journal: European urology oncology

Published: December 03, 2024

The protein deacetylase SIRT2 exerts metabolic control over adaptive β cell proliferation.

The protein deacetylase SIRT2 exerts metabolic control over adaptive β cell proliferation.

Journal: The Journal of clinical investigation

Published: September 16, 2024

Metabolic control of adaptive β-cell proliferation by the protein deacetylase SIRT2.

Metabolic control of adaptive β-cell proliferation by the protein deacetylase SIRT2.

Journal: bioRxiv : the preprint server for biology

Published: March 11, 2024

Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.

Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.

Journal: The Lancet. Oncology

Published: February 23, 2023

Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview Study.

Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview Study.

Journal: Oncology and therapy

Published: December 08, 2022

Engineered vasculature induces functional maturation of pluripotent stem cell-derived islet organoids.

Engineered vasculature induces functional maturation of pluripotent stem cell-derived islet organoids.

Journal: Developmental cell

Published: November 15, 2022

Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13.

Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13.

Journal: The patient

Published: April 26, 2022

Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes? An ISPOR Special Interest Group Report.

Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes? An ISPOR Special Interest Group Report.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: February 15, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026